Table of Content

1 Anthelmintic Drugs Market Overview
1.1 Product Overview and Scope of Anthelmintic Drugs
1.2 Anthelmintic Drugs Segment by Type
1.2.1 Global Anthelmintic Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral Drugs
1.2.3 Injectables
1.3 Anthelmintic Drugs Segment by Application
1.3.1 Anthelmintic Drugs Sales Comparison by Application: (2021-2027)
1.3.2 For Human
1.3.3 For Animal
1.4 Global Anthelmintic Drugs Market Size Estimates and Forecasts
1.4.1 Global Anthelmintic Drugs Revenue 2016-2027
1.4.2 Global Anthelmintic Drugs Sales 2016-2027
1.4.3 Anthelmintic Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anthelmintic Drugs Market Competition by Manufacturers
2.1 Global Anthelmintic Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anthelmintic Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anthelmintic Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anthelmintic Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anthelmintic Drugs Market Competitive Situation and Trends
2.5.1 Anthelmintic Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anthelmintic Drugs Players Market Share by Revenue
2.5.3 Global Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anthelmintic Drugs Retrospective Market Scenario by Region
3.1 Global Anthelmintic Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anthelmintic Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anthelmintic Drugs Market Facts & Figures by Country
3.3.1 North America Anthelmintic Drugs Sales by Country
3.3.2 North America Anthelmintic Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anthelmintic Drugs Market Facts & Figures by Country
3.4.1 Europe Anthelmintic Drugs Sales by Country
3.4.2 Europe Anthelmintic Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anthelmintic Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anthelmintic Drugs Sales by Region
3.5.2 Asia Pacific Anthelmintic Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anthelmintic Drugs Market Facts & Figures by Country
3.6.1 Latin America Anthelmintic Drugs Sales by Country
3.6.2 Latin America Anthelmintic Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anthelmintic Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anthelmintic Drugs Sales by Country
3.7.2 Middle East and Africa Anthelmintic Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anthelmintic Drugs Historic Market Analysis by Type
4.1 Global Anthelmintic Drugs Sales Market Share by Type (2016-2021)
4.2 Global Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Anthelmintic Drugs Price by Type (2016-2021)

5 Global Anthelmintic Drugs Historic Market Analysis by Application
5.1 Global Anthelmintic Drugs Sales Market Share by Application (2016-2021)
5.2 Global Anthelmintic Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Anthelmintic Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bayer Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cipla Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sun Pharmaceutical Industries Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Mankind Pharma
6.6.1 Mankind Pharma Corporation Information
6.6.2 Mankind Pharma Description and Business Overview
6.6.3 Mankind Pharma Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Mankind Pharma Product Portfolio
6.6.5 Mankind Pharma Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Anthelmintic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck Product Portfolio
6.8.5 Merck Recent Developments/Updates

7 Anthelmintic Drugs Manufacturing Cost Analysis
7.1 Anthelmintic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anthelmintic Drugs
7.4 Anthelmintic Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anthelmintic Drugs Distributors List
8.3 Anthelmintic Drugs Customers

9 Anthelmintic Drugs Market Dynamics
9.1 Anthelmintic Drugs Industry Trends
9.2 Anthelmintic Drugs Growth Drivers
9.3 Anthelmintic Drugs Market Challenges
9.4 Anthelmintic Drugs Market Restraints

10 Global Market Forecast
10.1 Anthelmintic Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anthelmintic Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anthelmintic Drugs by Type (2022-2027)
10.2 Anthelmintic Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anthelmintic Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anthelmintic Drugs by Application (2022-2027)
10.3 Anthelmintic Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anthelmintic Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anthelmintic Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anthelmintic Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anthelmintic Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anthelmintic Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anthelmintic Drugs Covered in This Study
Table 5. Global Anthelmintic Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anthelmintic Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Anthelmintic Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anthelmintic Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anthelmintic Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anthelmintic Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Anthelmintic Drugs Product Type
Table 12. Global Anthelmintic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anthelmintic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthelmintic Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anthelmintic Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Anthelmintic Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Anthelmintic Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anthelmintic Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Anthelmintic Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Anthelmintic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anthelmintic Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Anthelmintic Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anthelmintic Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Anthelmintic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anthelmintic Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anthelmintic Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anthelmintic Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anthelmintic Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anthelmintic Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anthelmintic Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anthelmintic Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Anthelmintic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anthelmintic Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anthelmintic Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anthelmintic Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anthelmintic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anthelmintic Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Anthelmintic Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Anthelmintic Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Anthelmintic Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anthelmintic Drugs Revenue Share by Type (2016-2021)
Table 42. Global Anthelmintic Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Anthelmintic Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Anthelmintic Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Anthelmintic Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anthelmintic Drugs Revenue Share by Application (2016-2021)
Table 47. Global Anthelmintic Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Novartis Anthelmintic Drugs Product
Table 52. Novartis Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer Anthelmintic Drugs Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Bayer Corporation Information
Table 59. Bayer Description and Business Overview
Table 60. Bayer Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Bayer Anthelmintic Drugs Product
Table 62. Bayer Recent Developments/Updates
Table 63. Cipla Corporation Information
Table 64. Cipla Description and Business Overview
Table 65. Cipla Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Cipla Anthelmintic Drugs Product
Table 67. Cipla Recent Developments/Updates
Table 68. Sun Pharmaceutical Industries Corporation Information
Table 69. Sun Pharmaceutical Industries Description and Business Overview
Table 70. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Sun Pharmaceutical Industries Anthelmintic Drugs Product
Table 72. Sun Pharmaceutical Industries Recent Developments/Updates
Table 73. Mankind Pharma Corporation Information
Table 74. Mankind Pharma Description and Business Overview
Table 75. Mankind Pharma Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Mankind Pharma Anthelmintic Drugs Product
Table 77. Mankind Pharma Recent Developments/Updates
Table 78. Johnson & Johnson Corporation Information
Table 79. Johnson & Johnson Description and Business Overview
Table 80. Johnson & Johnson Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Johnson & Johnson Anthelmintic Drugs Product
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Merck Corporation Information
Table 84. Merck Description and Business Overview
Table 85. Merck Anthelmintic Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Merck Anthelmintic Drugs Product
Table 87. Merck Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Anthelmintic Drugs Distributors List
Table 91. Anthelmintic Drugs Customers List
Table 92. Anthelmintic Drugs Market Trends
Table 93. Anthelmintic Drugs Growth Drivers
Table 94. Anthelmintic Drugs Market Restraints
Table 95. Global Anthelmintic Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Anthelmintic Drugs Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Anthelmintic Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Anthelmintic Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Anthelmintic Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Anthelmintic Drugs Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Anthelmintic Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Anthelmintic Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Anthelmintic Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Anthelmintic Drugs Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Anthelmintic Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Anthelmintic Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anthelmintic Drugs
Figure 2. Global Anthelmintic Drugs Market Share by Type in 2020 & 2027
Figure 3. Oral Drugs Product Picture
Figure 4. Injectables Product Picture
Figure 5. Global Anthelmintic Drugs Market Share by Application in 2020 & 2027
Figure 6. For Human
Figure 7. For Animal
Figure 8. Global Anthelmintic Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Anthelmintic Drugs Market Size 2016-2027 (US$ Million)
Figure 10. Global Anthelmintic Drugs Sales 2016-2027 (K Units)
Figure 11. Global Anthelmintic Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Anthelmintic Drugs Sales Share by Manufacturers in 2020
Figure 13. Global Anthelmintic Drugs Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Anthelmintic Drugs Players: Market Share by Revenue in 2020
Figure 15. Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Anthelmintic Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Anthelmintic Drugs Sales Market Share by Region in 2020
Figure 18. Global Anthelmintic Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Anthelmintic Drugs Revenue Market Share by Region in 2020
Figure 20. U.S. Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Anthelmintic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Anthelmintic Drugs by Type (2016-2021)
Figure 45. Sales Market Share of Anthelmintic Drugs by Application (2016-2021)
Figure 46. Sales Market Share of Anthelmintic Drugs by Application in 2020
Figure 47. Revenue Share of Anthelmintic Drugs by Application (2016-2021)
Figure 48. Revenue Share of Anthelmintic Drugs by Application in 2020
Figure 49. Manufacturing Cost Structure of Anthelmintic Drugs
Figure 50. Manufacturing Process Analysis of Anthelmintic Drugs
Figure 51. Anthelmintic Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed